Travere Therapeutics, Inc. (TVTX) SEC Filings — 2024
28 SEC filings for Travere Therapeutics, Inc. (TVTX) in 2024.
Filings
- Travere Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Travere Therapeutics, Inc. SC 13G Filing — SC 13G · Nov 14, 2024
- Travere Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 12, 2024
- Travere Therapeutics Files 8-K — 8-K · Nov 8, 2024
- Travere Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 8, 2024
- Travere Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 4, 2024
- Travere Therapeutics Files Q3 2024 10-Q — 10-Q · Oct 31, 2024
- Travere Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Oct 18, 2024
- Travere Therapeutics Relocates Principal Executive Offices — 8-K · Sep 26, 2024
- Travere Therapeutics Files 8-K for Financials — 8-K · Sep 6, 2024
- Travere Therapeutics Files Q2 2024 10-Q — 10-Q · Aug 1, 2024
- Travere Therapeutics Announces Board Changes and New CMO — 8-K · May 13, 2024
- Travere Therapeutics, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 6, 2024
- Travere Therapeutics, Inc. SC 13G Filing — SC 13G · May 1, 2024
- Travere Therapeutics Files 8-K with Exhibits — 8-K · Apr 24, 2024
- Travere Therapeutics Announces 2024 Annual Meeting of Stockholders on May 8, 2024 — DEF 14A · Mar 27, 2024
- Travere Therapeutics Files 8-K on Feb 23 for 'Other Events' — 8-K · Feb 23, 2024
- Travere Therapeutics, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Feb 20, 2024
- Travere Therapeutics Files 8-K on Financial Results — 8-K · Feb 15, 2024
- Travere Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Travere Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Travere Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- Janus Henderson Amends Travere Therapeutics Stake as of 12/31/23 — SC 13G/A · Feb 12, 2024
- Morgan Stanley Discloses Passive Stake in Travere Therapeutics — SC 13G · Feb 9, 2024
- Adage Capital Partners Amends Travere Therapeutics Stake — SC 13G/A · Feb 7, 2024
- State Street Corp Amends Travere Therapeutics Stake Filing — SC 13G/A · Jan 25, 2024
- BlackRock Amends Travere Therapeutics Stake (SC 13G/A) — SC 13G/A · Jan 24, 2024
- Travere Therapeutics Files 8-K on Financial Condition — 8-K · Jan 8, 2024